{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:40:26Z","timestamp":1778830826511,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7104","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1038\/nature05029","type":"journal-article","created":{"date-parts":[[2006,8,16]],"date-time":"2006-08-16T17:12:26Z","timestamp":1155748346000},"page":"779-785","source":"Crossref","is-referenced-by-count":317,"title":["PML inhibits HIF-1\u03b1 translation and neoangiogenesis through repression of mTOR"],"prefix":"10.1038","volume":"442","author":[{"given":"Rosa","family":"Bernardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhem","family":"Guernah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Grisendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Alimonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Teruya-Feldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cordon-Cardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Celeste Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Rafii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Paolo","family":"Pandolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnature05029_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353\u2013364 (1996)","journal-title":"Cell"},{"key":"BFnature05029_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara, N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581\u2013611 (2004)","journal-title":"Endocr. Rev."},{"key":"BFnature05029_CR3","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/S1471-4914(02)02317-1","volume":"8","author":"GL Semenza","year":"2002","unstructured":"Semenza, G. L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8, S62\u2013S67 (2002)","journal-title":"Trends Mol. Med."},{"key":"BFnature05029_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0092-8674(91)90113-D","volume":"66","author":"H de The","year":"1991","unstructured":"de The, H. et al. The PML-RAR\u03b1 fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675\u2013684 (1991)","journal-title":"Cell"},{"key":"BFnature05029_CR5","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.1720570","volume":"254","author":"AD Goddard","year":"1991","unstructured":"Goddard, A. D., Borrow, J., Freemont, P. S. & Solomon, E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371\u20131374 (1991)","journal-title":"Science"},{"key":"BFnature05029_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0092-8674(91)90112-C","volume":"66","author":"A Kakizuka","year":"1991","unstructured":"Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR\u03b1 with a novel putative transcription factor, PML. Cell 66, 663\u2013674 (1991)","journal-title":"Cell"},{"key":"BFnature05029_CR7","first-page":"1285","volume":"6","author":"PP Pandolfi","year":"1991","unstructured":"Pandolfi, P. P. et al. Structure and origin of the acute promyelocytic leukemia myl\/RAR\u03b1 cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6, 1285\u20131292 (1991)","journal-title":"Oncogene"},{"key":"BFnature05029_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1084\/jem.193.4.521","volume":"193","author":"EM Rego","year":"2001","unstructured":"Rego, E. M. et al. Role of promyelocytic leukemia (PML) protein in tumor suppression. J. Exp. Med. 193, 521\u2013529 (2001)","journal-title":"J. Exp. Med."},{"key":"BFnature05029_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(02)00626-8","volume":"108","author":"P Salomoni","year":"2002","unstructured":"Salomoni, P. & Pandolfi, P. P. The role of PML in tumor suppression. Cell 108, 165\u2013170 (2002)","journal-title":"Cell"},{"key":"BFnature05029_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/3073","volume":"20","author":"ZG Wang","year":"1998","unstructured":"Wang, Z. G. et al. PML is essential for multiple apoptotic pathways. Nature Genet. 20, 266\u2013272 (1998)","journal-title":"Nature Genet."},{"key":"BFnature05029_CR11","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1126\/science.279.5356.1547","volume":"279","author":"ZG Wang","year":"1998","unstructured":"Wang, Z. G. et al. Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547\u20131551 (1998)","journal-title":"Science"},{"key":"BFnature05029_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature04809","volume":"441","author":"LC Trotman","year":"2006","unstructured":"Trotman, L. C. et al. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441, 523\u2013527 (2006)","journal-title":"Nature"},{"key":"BFnature05029_CR13","first-page":"1315","volume":"10","author":"MH Koken","year":"1995","unstructured":"Koken, M. H. et al. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10, 1315\u20131324 (1995)","journal-title":"Oncogene"},{"key":"BFnature05029_CR14","first-page":"2023","volume":"149","author":"M Gambacorta","year":"1996","unstructured":"Gambacorta, M. et al. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am. J. Pathol. 149, 2023\u20132035 (1996)","journal-title":"Am. J. Pathol."},{"key":"BFnature05029_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<599::AID-IJC1>3.0.CO;2-#","volume":"85","author":"P Zhang","year":"2000","unstructured":"Zhang, P. et al. Lack of expression for the suppressor PML in human small cell lung carcinoma. Int. J. Cancer 85, 599\u2013605 (2000)","journal-title":"Int. J. Cancer"},{"key":"BFnature05029_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/jnci\/djh043","volume":"96","author":"C Gurrieri","year":"2004","unstructured":"Gurrieri, C. et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl Cancer Inst. 96, 269\u2013279 (2004)","journal-title":"J. Natl Cancer Inst."},{"key":"BFnature05029_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature02783","volume":"431","author":"HK Lin","year":"2004","unstructured":"Lin, H. K., Bergmann, S. & Pandolfi, P. P. Cytoplasmic PML function in TGF-\u03b2 signalling. Nature 431, 205\u2013211 (2004)","journal-title":"Nature"},{"key":"BFnature05029_CR18","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1038\/sj.onc.1207533","volume":"23","author":"Y Takahashi","year":"2004","unstructured":"Takahashi, Y., Lallemand-Breitenbach, V., Zhu, J. & de The, H. PML nuclear bodies and apoptosis. Oncogene 23, 2819\u20132824 (2004)","journal-title":"Oncogene"},{"issue":"suppl. 1","key":"BFnature05029_CR19","first-page":"44","volume":"82","author":"HH Marti","year":"1999","unstructured":"Marti, H. H. & Risau, W. Angiogenesis in ischemic disease. Thromb. Haemost. 82 (suppl. 1), 44\u201352 (1999)","journal-title":"Thromb. Haemost."},{"key":"BFnature05029_CR20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nm0603-702","volume":"9","author":"S Rafii","year":"2003","unstructured":"Rafii, S. & Lyden, D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nature Med. 9, 702\u2013712 (2003)","journal-title":"Nature Med."},{"key":"BFnature05029_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S1471-4914(03)00021-2","volume":"9","author":"SY Rabbany","year":"2003","unstructured":"Rabbany, S. Y., Heissig, B., Hattori, K. & Rafii, S. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol. Med. 9, 109\u2013117 (2003)","journal-title":"Trends Mol. Med."},{"key":"BFnature05029_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nm1101-1194","volume":"7","author":"D Lyden","year":"2001","unstructured":"Lyden, D. et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med. 7, 1194\u20131201 (2001)","journal-title":"Nature Med."},{"key":"BFnature05029_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.yjmcc.2004.01.006","volume":"36","author":"K Amano","year":"2004","unstructured":"Amano, K. et al. Mechanism for IL-1\u03b2-mediated neovascularization unmasked by IL-1\u03b2 knock-out mice. J. Mol. Cell. Cardiol. 36, 469\u2013480 (2004)","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnature05029_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza, G. L. Targeting HIF-1 for cancer therapy. Nature Rev. Cancer 3, 721\u2013732 (2003)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature05029_CR25","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1101\/gad.1003602","volume":"16","author":"WG Kaelin Jr.","year":"2002","unstructured":"Kaelin, W. G. Jr. How oxygen makes its presence felt. Genes Dev. 16, 1441\u20131445 (2002)","journal-title":"Genes Dev."},{"key":"BFnature05029_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.critrevonc.2004.09.003","volume":"53","author":"C Brahimi-Horn","year":"2005","unstructured":"Brahimi-Horn, C. & Pouyssegur, J. When hypoxia signalling meets the ubiquitin-proteasomal pathway, new targets for cancer therapy. Crit. Rev. Oncol. Hematol. 53, 115\u2013123 (2005)","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"BFnature05029_CR27","doi-asserted-by":"publisher","first-page":"29655","DOI":"10.1074\/jbc.M212770200","volume":"278","author":"AM Arsham","year":"2003","unstructured":"Arsham, A. M., Howell, J. J. & Simon, M. C. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J. Biol. Chem. 278, 29655\u201329660 (2003)","journal-title":"J. Biol. Chem."},{"key":"BFnature05029_CR28","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas, J. et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev. 18, 2893\u20132904 (2004)","journal-title":"Genes Dev."},{"key":"BFnature05029_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.molcel.2006.01.010","volume":"21","author":"L Liu","year":"2006","unstructured":"Liu, L. et al. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol. Cell 21, 521\u2013531 (2006)","journal-title":"Mol. Cell"},{"key":"BFnature05029_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/excr.1999.4683","volume":"253","author":"A Dufner","year":"1999","unstructured":"Dufner, A. & Thomas, G. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253, 100\u2013109 (1999)","journal-title":"Exp. Cell Res."},{"key":"BFnature05029_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tibs.2004.11.003","volume":"30","author":"LS Harrington","year":"2005","unstructured":"Harrington, L. S., Findlay, G. M. & Lamb, R. F. Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem. Sci. 30, 35\u201342 (2005)","journal-title":"Trends Biochem. Sci."},{"key":"BFnature05029_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ceb.2005.02.008","volume":"17","author":"DE Martin","year":"2005","unstructured":"Martin, D. E. & Hall, M. N. The expanding TOR signaling network. Curr. Opin. Cell Biol. 17, 158\u2013166 (2005)","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnature05029_CR33","doi-asserted-by":"publisher","first-page":"23433","DOI":"10.1074\/jbc.C500169200","volume":"280","author":"X Long","year":"2005","unstructured":"Long, X., Ortiz-Vega, S. & Avruch, J. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J. Biol. Chem. 280, 23433\u201323436 (2005)","journal-title":"J. Biol. Chem."},{"key":"BFnature05029_CR34","doi-asserted-by":"publisher","first-page":"14340","DOI":"10.1073\/pnas.011511898","volume":"97","author":"JE Kim","year":"2000","unstructured":"Kim, J. E. & Chen, J. Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. Proc. Natl Acad. Sci. USA 97, 14340\u201314345 (2000)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature05029_CR35","doi-asserted-by":"publisher","first-page":"31423","DOI":"10.1074\/jbc.M204080200","volume":"277","author":"IH Park","year":"2002","unstructured":"Park, I. H., Bachmann, R., Shirazi, H. & Chen, J. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. J. Biol. Chem. 277, 31423\u201331429 (2002)","journal-title":"J. Biol. Chem."},{"key":"BFnature05029_CR36","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1158\/0008-5472.CAN-05-1083","volume":"65","author":"S Paglin","year":"2005","unstructured":"Paglin, S. et al. Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. Cancer Res. 65, 11061\u201311070 (2005)","journal-title":"Cancer Res."},{"key":"BFnature05029_CR37","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1038\/sj.onc.1204765","volume":"20","author":"K Jensen","year":"2001","unstructured":"Jensen, K., Shiels, C. & Freemont, P. S. PML protein isoforms and the RBCC\/TRIM motif. Oncogene 20, 7223\u20137233 (2001)","journal-title":"Oncogene"},{"key":"BFnature05029_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1182\/blood.V100.3.905","volume":"100","author":"M Corada","year":"2002","unstructured":"Corada, M. et al. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood 100, 905\u2013911 (2002)","journal-title":"Blood"},{"key":"BFnature05029_CR39","first-page":"2567","volume":"62","author":"F Liao","year":"2002","unstructured":"Liao, F. et al. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res. 62, 2567\u20132575 (2002)","journal-title":"Cancer Res."},{"key":"BFnature05029_CR40","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1038\/sj.onc.1204852","volume":"20","author":"J Zhu","year":"2001","unstructured":"Zhu, J., Lallemand-Breitenbach, V. & de The, H. Pathways of retinoic acid- or arsenic trioxide-induced PML\/RAR\u03b1 catabolism, role of oncogene degradation in disease remission. Oncogene 20, 7257\u20137265 (2001)","journal-title":"Oncogene"},{"key":"BFnature05029_CR41","first-page":"871","volume":"11","author":"C Lavau","year":"1995","unstructured":"Lavau, C. et al. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11, 871\u2013876 (1995)","journal-title":"Oncogene"},{"key":"BFnature05029_CR42","first-page":"2027","volume":"9","author":"MK Chelbi-Alix","year":"1995","unstructured":"Chelbi-Alix, M. K. et al. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9, 2027\u20132033 (1995)","journal-title":"Leukemia"},{"key":"BFnature05029_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1535-6108(03)00275-7","volume":"4","author":"CL Sawyers","year":"2003","unstructured":"Sawyers, C. L. Will mTOR inhibitors make it as cancer drugs? Cancer Cell 4, 343\u2013348 (2003)","journal-title":"Cancer Cell"},{"key":"BFnature05029_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/annonc\/mdi113","volume":"16","author":"S Vignot","year":"2005","unstructured":"Vignot, S., Faivre, S., Aguirre, D. & Raymond, E. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann. Oncol. 16, 525\u2013537 (2005)","journal-title":"Ann. Oncol."},{"key":"BFnature05029_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ncb1147","volume":"6","author":"R Bernardi","year":"2004","unstructured":"Bernardi, R. et al. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nature Cell Biol. 6, 665\u2013672 (2004)","journal-title":"Nature Cell Biol."},{"key":"BFnature05029_CR46","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296\u20131302 (2004)","journal-title":"Curr. Biol."},{"key":"BFnature05029_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature03915","volume":"437","author":"S Grisendi","year":"2005","unstructured":"Grisendi, S. et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437, 147\u2013153 (2005)","journal-title":"Nature"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature05029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature05029","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature05029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature05029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:58:01Z","timestamp":1684432681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature05029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":47,"journal-issue":{"issue":"7104","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["BFnature05029"],"URL":"https:\/\/doi.org\/10.1038\/nature05029","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}